Envestnet Asset Management Inc Mereo Biopharma Group PLC Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.3 - $4.05 $20,088 - $35,372
8,734 Added 18.52%
55,903 $184,000
Q4 2023

Feb 13, 2024
BUY
$1.19 - $2.42 $56,131 - $114,148
47,169 New
47,169 $108,000
Q2 2023

Aug 04, 2023
BUY
$0.79 - $1.43 $59,034 - $106,859
74,727 New
74,727 $98,000
Q3 2022

Nov 10, 2022
BUY
$0.82 - $1.73 $30,640 - $64,644
37,367 New
37,367 $32,000

Others Institutions Holding MREO

# of Institutions
86
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $376M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email